PROLIFERATIVE VITREORETINOPATHY
Clinical trials for PROLIFERATIVE VITREORETINOPATHY explained in plain language.
Never miss a new study
Get alerted when new PROLIFERATIVE VITREORETINOPATHY trials appear
Sign up with your email to follow new studies for PROLIFERATIVE VITREORETINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Chemo drug injected into eyes to stop scarring and save sight
Disease control Not yet recruitingThis early-stage trial is testing if a drug called topotecan, injected into the eye during and after surgery, can help prevent a serious complication called proliferative vitreoretinopathy (PVR). PVR causes scarring that can make retinal detachment surgery fail. The study will co…
Matched conditions: PROLIFERATIVE VITREORETINOPATHY
Phase: PHASE1 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
AI and eye fluid analysis could predict dangerous scarring after retinal surgery
Knowledge-focused Not yet recruitingThis study aims to understand why some people develop problematic scarring (called PVR) after surgery to repair a detached retina. Researchers will analyze fluid from the eye and use special imaging and AI to look for signs that predict who is at high risk. The goal is to gather …
Matched conditions: PROLIFERATIVE VITREORETINOPATHY
Sponsor: University College, London • Aim: Knowledge-focused
Last updated Apr 02, 2026 03:41 UTC